https://www.selleckchem.com/pr....oducts/mpi-0479605.h
nisms of the HFD-induced obesity, which also supplied clues for the future mechanism studies of CQR's anti-obesity effects.Nonalcoholic fatty liver disease (NAFLD), especially its advanced stage nonalcoholic steatohepatitis (NASH), has become a threatened public health problem worldwide. However, no specific drug has been approved for clinical use to treat patients with NASH, though there are many promising candidates against NAFLD in the drug development pipeline. Recently, accumulated evidence showed that liver sinusoidal endothel
Like
Comment
Share
